Crisi Giovanna M, Marconi Sharon A, Makari-Judson Grace, Goulart Robert A
Department of Pathology, Baystate Medical Center/Tufts University School of Medicine, Springfield, MA 01199, USA.
Am J Clin Pathol. 2005 Nov;124(5):733-9. doi: 10.1309/61MV-ENEK-5EJ7-JKGF.
Breast adenoid cystic carcinoma (BACC) is a biologically distinct tumor with morphologic mimickers, which might make accurate classification problematic. Because c-kit expression has been reported in adenoid cystic carcinoma of various anatomic sites, we evaluated BACC for c-kit by immunohistochemical analysis, comparing the findings to similarly stained mimickers. Tested cases included 6 BACCs, 15 low-grade infiltrating ductal carcinomas (LGIDCs) chosen as potential mimickers, and 15 head-neck adenoid cystic carcinomas (HNACCs). All BACCs showed plasma membranous and cytoplasmic staining equal to or greater than that of adjacent benign epithelium. Five BACCs (83%) expressed c-kit in more than 50% of tumor cells. Only 2 of 15 LGIDCs expressed low-intensity, focal c-kit staining. Of the 15 HNACCs, 10 (67%) expressed c-kit. Hormone receptors were consistently negative in BACCs. All BACCs expressed c-kit, whereas LGIDCs infrequently expressed low-intensity c-kit. Immunohistochemical evaluation for c-kit might aid in accurately classifying carcinomas with histologic features overlapping adenoid cystic carcinoma and LGIDC.
乳腺腺样囊性癌(BACC)是一种生物学特性独特的肿瘤,存在形态学上的相似肿瘤,这可能使准确分类存在问题。由于已有报道称c-kit在各种解剖部位的腺样囊性癌中表达,我们通过免疫组织化学分析评估了BACC中的c-kit,将结果与染色相似的相似肿瘤进行比较。检测的病例包括6例BACC、15例被选为潜在相似肿瘤的低级别浸润性导管癌(LGIDC)和15例头颈部腺样囊性癌(HNACC)。所有BACC均显示出与相邻良性上皮相等或更强的细胞膜和细胞质染色。5例BACC(83%)在超过50%的肿瘤细胞中表达c-kit。15例LGIDC中只有2例表达低强度、局灶性c-kit染色。在15例HNACC中,10例(67%)表达c-kit。BACC中的激素受体始终为阴性。所有BACC均表达c-kit,而LGIDC很少表达低强度c-kit。对c-kit进行免疫组织化学评估可能有助于准确分类具有与腺样囊性癌和LGIDC重叠的组织学特征的癌。